New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

June 8, 2025

Study Completion Date

December 7, 2025

Conditions

Parkinson Disease

Interventions

PROCEDURE

fMRI-3T

fMRI-3T will be performed during the visit 1: day of anesthesia consultation (this fMRI-3T will last approximately one hour)

Trial Locations (1)

GHPS, Paris

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02800460 - New Approaches in MRI at 3T Dedicated to Targeting Subthalamic Nucleus on Parkinsonian Patients | Biotech Hunter | Biotech Hunter